| Related Articles |
EEG functional networks reveal global effects of Methylphenidate in youth with Attention Deficit/Hyperactivity Disorder.
Brain Connect. 2019 Mar 28;:
Authors: Rubinson M, Horowitz I, Naim-Feil J, Gothelf D, Moses E, Levit-Binnun N
Abstract
Methylphenidate is the leading drug for treatment of Attention Deficit/Hyperactivity Disorder (ADHD), yet its underlying neuronal mechanisms are still unclear. Here we use a dynamical brain networks approach to explore the effects of cognitive effort and Methylphenidate on ADHD subjects. Electroencephalography data were recorded from 19 ADHD subjects and 18 controls during a Go/No-Go Task. ADHD subjects completed the task twice a day over two days. The second session was administered post ingestion of placebo/Methylphenidate (alternately). Controls performed two tasks in one day. The data were divided into 300ms windows from -300 pre-stimulus until 1200ms post-stimulus. Brain networks were constructed per subject and window, from which network metrics were extracted and compared across the experimental conditions. We identified an immediate shift of global connectivity and of network segregation following the stimulus for both groups, followed by a gradual return to baseline. Decreased global connectivity was found 400-700ms post-stimulus in ADHD compared to controls, and was normalized post Methylphenidate. An increase of the networks’ segregation occurred post placebo at 100-400ms and 400-700ms post-stimulus, yet was inhibited post Methylphenidate. These global alterations resulted mainly from changes in task-relevant frontal and parietal regions. The networks of medicated ADHD subjects and controls exhibited a more significant and lasting change, relative to baseline, compared to those of non-medicated ADHD. These results suggest impaired network flexibility in ADHD, corrected by Methylphenidate.
PMID: 30919658 [PubMed – as supplied by publisher]
via https://www.ncbi.nlm.nih.gov/pubmed/30919658?dopt=Abstract
